PolyPid Ltd.
PYPD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001611842
No open-market purchases or sales by PolyPid Ltd. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $16.7M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in PolyPid Ltd. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 13
- −1 vs. Q4 2024
- Shares held
- 2.54M
- +73.6K (+3.0%) vs. Q4 2024
- Total value
- $6.90M
- −$608.1K (−8.1%) vs. Q4 2024
- New holders
- 1
- 1 more added
- Sold out
- 2
- 1 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PYPD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 33 | $16.7M |
| Q1 2026 | 19 | $13.7M |
| Q4 2025 | 19 | $13.0M |
| Q3 2025 | 16 | $9.45M |
| Q2 2025 | 15 | $10.2M |
| Q1 2025 | 13 | $6.90M |
| Q4 2024 | 14 | $7.50M |
| Q3 2024 | 12 | $6.64M |
| Q2 2024 | 9 | $5.18M |
| Q1 2024 | 8 | $5.13M |
| Q4 2023 | 5 | $79.6K |
| Q3 2023 | 4 | $93.2K |
| Q2 2023 | 14 | $155.2K |
| Q1 2023 | 11 | $147.8K |
| Q4 2022 | 13 | $265.3K |
| Q3 2022 | 18 | $566.0K |
| Q2 2022 | 27 | $4.95M |
| Q1 2022 | 27 | $6.10M |
| Q4 2021 | 27 | $8.71M |
| Q3 2021 | 19 | $11.9M |
| Q2 2021 | 22 | $14.9M |
| Q1 2021 | 20 | $14.7M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding PolyPid Ltd.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SBI Securities Co., Ltd. | 1 | $3 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 467 | $1.26K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 834 | $2.26K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 878 | $2.38K | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 7,346 | $19.9K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 10,558 | $28.6K | 0.00% | +10,558 | New |
| Yelin Lapidot Holdings Management Ltd. | 11,153 | $30.2K | 0.01% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 54,975 | $149.0K | 0.17% | −48,693−47.0% | Reduced |
| ADAR1 Capital Management, LLC | 80,080 | $217.0K | 0.04% | 00.0% | Unchanged |
| J. Goldman & Co LP | 128,483 | $348.2K | 0.01% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 291,273 | $789.4K | 0.22% | 00.0% | Unchanged |
| AIGH Capital Management LLC | 940,381 | $2.55M | 1.32% | +112,514+13.6% | Added |
| Rosalind Advisors, Inc. | 1,018,021 | $2.76M | 1.34% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 0 | $0 | 0.00% | −781−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −4−100.0% | Sold out |